| Date Filed | Type | Description |
| 03/23/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 03/23/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 03/23/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 03/13/2017 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)] |
| 03/13/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 03/13/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 03/13/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 03/13/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 03/13/2017 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement |
| 03/13/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 03/13/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 03/13/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 03/13/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 03/13/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 03/13/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 03/13/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 03/01/2017 |
4
| Henighan Michael P (CFO) has filed a Form 4 on WaferGen Bio-systems, Inc. |
| 03/01/2017 |
4
| Carlson Rolland (CEO and President) has filed a Form 4 on WaferGen Bio-systems, Inc. |
| 03/01/2017 |
4
| TRIFUNOVICH IVAN (Director) has filed a Form 4 on WaferGen Bio-systems, Inc.|
Txns:
| Disposed/sold 58,469 options to buy
@ $2.8, valued at
$163.7k
|
|
| 03/01/2017 |
4
| Schueren Robert Alan (Director) has filed a Form 4 on WaferGen Bio-systems, Inc.|
Txns:
| Disposed/sold 8,368 shares
@ $7.3471, valued at
$61.5k
|
|
| 03/01/2017 |
4
| McKenzie William Douglas (Director) has filed a Form 4 on WaferGen Bio-systems, Inc. |
| 03/01/2017 |
4
| KANTER JOEL S (Director) has filed a Form 4 on WaferGen Bio-systems, Inc.|
Txns:
| Disposed/sold 8,617 shares
@ $7.3471, valued at
$63.3k
Disposed/sold 89 warrants
@ $130, valued at
$11.6k
|
|
| 03/01/2017 |
4
| Kaneshiro Makoto (Director) has filed a Form 4 on WaferGen Bio-systems, Inc. |
| 03/01/2017 |
4
| Hautamaki R Dean (Director) has filed a Form 4 on WaferGen Bio-systems, Inc. |
| 03/01/2017 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
| 03/01/2017 |
8-K
| Quarterly results |
| 02/23/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 02/15/2017 |
8-K
| Form 8-K - Current report |
| 01/06/2017 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 10% stake in WaferGen Bio-systems, Inc. |
| 01/04/2017 |
4
| Schueren Robert Alan (Director) has filed a Form 4 on WaferGen Bio-systems, Inc. |
| 01/04/2017 |
4
| McKenzie William Douglas (Director) has filed a Form 4 on WaferGen Bio-systems, Inc. |
| 01/04/2017 |
4
| KANTER JOEL S (Director) has filed a Form 4 on WaferGen Bio-systems, Inc.|
Txns:
| Granted 3,049 shares
@ $0 |
|
| 01/04/2017 |
4
| Kaneshiro Makoto (Director) has filed a Form 4 on WaferGen Bio-systems, Inc. |
|